CE-marked in vitro diagnostic test for early detection of acute kidney injury using the NGAL biomarker. Provides rapid results to guide clinical interventions for kidney damage assessment in critically ill patients.
Manufactured by
BioPorto Diagnostics
United States
ProNephro AKI (NGAL) is designed to aid in the risk assessment of acute kidney injury (AKI) in ICU patients 3 months to 22 years. A low NGAL value indicates a low risk of AKI, allowing for confident use of interventions such as fluids, diuretics, or nephrotoxic medications. Elevated NGAL values signal a high risk of developing AKI and can trigger nephrology consults and interventions 2-3 days before serum creatinine rises.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hangzhou Elit Biotech Co.,Ltd.
China · 1 relevant product
PRIMA Lab SA
Switzerland · 2 relevant products
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China · 2 relevant products
64 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 107 closest product alternatives
Hangzhou Elit Biotech Co.,Ltd. · China
A rapid diagnostic test for the detection of Neutrophil Gelatinase-Associated Lipocalin (NGAL), a biomarker used in clinical assessment.
PRIMA Lab SA · Switzerland
The first rapid test for semi-quantitative detection of NGAL in urine for early screening of kidney damage in dogs
Shenzhen Kingfocus Biomedical Engineering Co., Ltd. · China
Diagnostic assays for detection of kidney injury markers in serum and urine samples. Enables early identification and monitoring of acute and chronic renal dysfunction.
104 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products